7th Annual Cancer & Immunotherapy Symposium
Bringing the immuno-oncology community together to discuss the latest research
xCELLigence® Liquid Tumor Immunotherapy Potency Assay
Evaluate Functional Potency of Immunotherapies Targeting Tumors of B Cell Origin.
RTCA Software Pro
New xCELLigence Software Package Designed for Immuno-Oncology Applications
Now a part of Agilent
On November 14th, 2018, Agilent completed the acquisition of ACEA Biosciences.
For answers to common questions about ACEA Biosciences and Agilent, please click here.
ACEA products are used by researchers across the globe for drug discovery and development, toxicology, flow cytometry, cell analysis, safety pharmacology, disease studies, clinical diagnostics, and basic research.